Premium
Barrett's esophagus: proton pump inhibitors and chemoprevention II
Author(s) -
Richter Joel E.,
Penagini Roberto,
Pohl Daniel,
Dvorak Katerina,
Goldman Aaron,
Savarino Edoardo,
Zentilin Patrizia,
Savarino Vincenzo,
Watson Joshua T.,
Wong Roy K.H.,
Pace Fabio,
Casini Valentina,
Peura David A.,
Herzig Shoshana Joy,
Kamiya Takeshi,
Pelosini Iva,
Scarpignato Carmelo,
Armstrong David,
DeVault Kenneth R.,
Bechi Paolo,
Taddei Antonio,
Freschi Giancarlo,
Ringressi Maria Novella,
Degli'Innocenti Duccio Rossi,
Castiglione Francesca,
Masini Emmanuella,
Hunt Richard H.
Publication year - 2011
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2011.06048.x
Subject(s) - barrett's esophagus , esophagus , chemistry , pharmacology , medicine , adenocarcinoma , cancer
The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring, pH‐impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual‐release delivery PPIs, immediate‐release PPIs, long‐term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti‐inflammatory drugs (NSAIDs), and new PPIs.